Vascular neurocognitive disorder is a decline in thinking ability caused by reduced blood flow to the brain. It is the second most common cause of dementia after Alzheimer’s disease, accounting for roughly 27% to 33% of dementia risk when researchers control for other contributing factors. The condition ranges from mild cognitive changes that don’t interfere with daily independence to major impairment that requires help with everyday tasks like managing finances or medications.
How It Differs From Alzheimer’s Disease
The earliest signs of vascular neurocognitive disorder typically affect the speed of thinking and problem-solving rather than memory. People often notice they have trouble paying attention, organizing their thoughts, planning tasks, or figuring out what to do next. Confusion, difficulty finding the right words, and slowed thinking are common. Memory problems can develop too, but they tend to appear later and are less prominent in the early stages compared to Alzheimer’s, where forgetting recent events is usually the first red flag.
Symptoms depend heavily on which part of the brain has lost blood supply. Someone with damage to areas involved in movement may also experience balance problems or changes in gait alongside cognitive changes. This variability makes the condition look different from person to person.
What Happens Inside the Brain
The underlying problem is damage to the brain’s small blood vessels, a condition called cerebral small vessel disease. These tiny arteries and arterioles supply blood to deep brain structures and the white matter that connects different brain regions. When they stiffen, narrow, or become leaky, the tissue they supply suffers.
This damage shows up on brain MRI scans in several recognizable forms: white matter hyperintensities (bright spots on certain MRI sequences), small deep infarcts where tissue has died, tiny microbleeds just 2 to 5 millimeters across, and enlarged spaces around blood vessels. White matter lesions tend to appear first in areas farthest from where the penetrating arteries originate, because those regions are most vulnerable to reduced blood flow. The protective barrier between blood vessels and brain tissue can also become leaky, allowing fluid to seep into surrounding white matter and cause further injury.
Lacunes, which are small fluid-filled cavities 3 to 15 millimeters across, form as the end result of small infarcts or microbleeds deep in the brain. The number of these lacunes is a strong predictor of disability and cognitive impairment. In people over 70, hardening of these small arteries is extremely common in autopsy studies and closely linked to the accumulation of white matter damage.
The Stepwise Pattern of Decline
Vascular neurocognitive disorder has a characteristic progression pattern that clinicians describe as “stepwise.” Rather than the slow, steady slide seen in Alzheimer’s, cognitive function often holds relatively stable for a period, then drops after a new vascular event like a stroke or series of silent microinfarcts. Research tracking stroke survivors over time has confirmed this two-stage pattern: a period of cognitive stability followed by relatively rapid decline, often triggered by additional brain injury.
This happens because the brain has a reserve capacity. A single stroke may reduce that reserve without producing obvious cognitive symptoms. The person functions normally but in a state of heightened vulnerability. When another event hits, even a small one, it can push the brain past the threshold where it can compensate, and thinking abilities drop noticeably. People who develop dementia within three years of a stroke tend to have evidence of previous brain injury already. Those who develop it later often had milder initial strokes but accumulated damage over time.
Mild vs. Major Stages
The diagnosis is split into two levels based on how much cognitive decline affects daily life. In the mild stage, a person notices that tasks take more effort. They might need lists, reminders, or extra time to do things they used to handle easily. Formal testing shows modest deficits, typically scoring between the 3rd and 16th percentile compared to peers of the same age and education. The key distinction is that independence is preserved, even if maintaining it requires workarounds.
In the major stage (what most people call dementia), deficits are severe enough that the person can no longer manage complex tasks independently. Test scores typically fall below the 3rd percentile. At this point, someone else needs to step in to help with things like paying bills, keeping track of medications, or handling appointments. The threshold for this diagnosis is specifically the loss of independence in these kinds of tasks.
Risk Factors You Can Influence
High blood pressure and diabetes are the two most prominent modifiable risk factors, and having both together raises risk more than either alone. In a large case-control study, people with both hypertension and diabetes had 53% higher odds of developing dementia compared to people with neither condition. Hypertension alone raised the odds by 18%, and diabetes alone by 26%. These numbers matter because both conditions directly damage the small blood vessels that feed the brain’s deep structures.
Smoking, obesity, physical inactivity, depression, and social isolation also contribute to risk. Many of these overlap with the risk factors for heart disease, which makes sense given that the same blood vessel damage underlies both conditions.
What Helps Slow Progression
Because vascular neurocognitive disorder is driven by blood vessel damage, the most effective strategies target cardiovascular health. Managing blood pressure and blood sugar, staying physically active, and not smoking all protect the brain’s small vessels from further injury.
Diet plays a measurable role. In one large study of adults 65 and older, high vegetable intake was associated with a 38% lower risk of dementia, and eating omega-3 fatty acids at least once a week lowered risk by 60%. On the flip side, diets high in saturated fat and trans fats more than doubled the risk. Multidomain lifestyle interventions, combining diet, exercise, cognitive training, and vascular risk monitoring, appear more effective than changing just one habit. The Finnish FINGER trial demonstrated this approach: after two years, participants receiving the combined intervention scored 25% higher on global cognition than a control group whose cognitive function declined over the same period.
How It Is Diagnosed
Diagnosis requires both evidence of cognitive decline on formal testing and evidence that vascular disease is the likely cause. Brain MRI is the primary tool for identifying vascular damage. Clinicians often use the Fazekas scale, a 0-to-3 rating system, to grade white matter damage in two locations: near the brain’s central fluid chambers (periventricular) and in deeper brain tissue (deep white matter). A score of 2 or higher in either location, combined with cognitive symptoms, points toward a vascular cause. Grade 2 periventricular lesions look like an irregular bright halo around the ventricles, while grade 2 deep lesions show scattered bright spots that are starting to merge together.
The timing and pattern of symptoms also help distinguish vascular causes from other types of dementia. A history of strokes, a stepwise decline, and early problems with processing speed and executive function rather than memory all point toward a vascular origin.
Life Expectancy After Diagnosis
Survival after a diagnosis of vascular dementia is generally shorter than for Alzheimer’s disease. Data from the National Alzheimer’s Coordinating Center show a median survival of 4 years for vascular dementia, compared to 6 years for Alzheimer’s and 5 years for frontotemporal dementia. Other studies report median survival ranging from 3.3 to 9.1 years, reflecting wide variation based on the severity of vascular disease, the person’s age at diagnosis, and what other health conditions they have. The shorter survival likely reflects the fact that the same cardiovascular damage affecting the brain is also affecting the heart and other organs.